| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 21.762 | 1.124 | 0 | 5.305 |
| Total Income - EUR | - | - | - | - | - | - | 21.970 | 1.308 | 0 | 5.529 |
| Total Expenses - EUR | - | - | - | - | - | - | 33.630 | 16.462 | 14.978 | 17.350 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -11.660 | -15.154 | -14.978 | -11.821 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -11.881 | -15.166 | -14.978 | -11.876 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Grapoila Bio Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 554 | 309 | 62 | 0 |
| Current Assets | - | - | - | - | - | - | 38.422 | 29.236 | 22.015 | 21.931 |
| Inventories | - | - | - | - | - | - | 15.100 | 15.197 | 15.151 | 15.066 |
| Receivables | - | - | - | - | - | - | 6.341 | 7.087 | 6.721 | 6.660 |
| Cash | - | - | - | - | - | - | 16.981 | 6.952 | 143 | 205 |
| Shareholders Funds | - | - | - | - | - | - | -11.840 | -27.042 | -41.938 | -53.580 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 50.833 | 56.587 | 64.015 | 75.511 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "164 - 164" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Grapoila Bio Prod S.r.l.